8-K/AThe WireRoutine
Company Update
Filed Aug 8, 2024 · 1y ago · Accession 0001636282-24-000058
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 8-K/A
- Filing date
- Aug 8, 2024
- Report date
- Aug 7, 2024
- Document
- syre-20240807.htm
- Size
- 160 KB